Mironid

News

Recent biotech financings are headed by LifeMine's $263m for a transplant drug, with Expedition, Ratio, Vedanta, and Mironid also in on the action.

News

At its third attempt, Replimune has finally won FDA approval for its advanced melanoma treatment RP1, now named Tudriqev and its first product.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.